The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of lifileucel in advanced melanoma: A single-institution experience.
 
Kelly Mahuron
Consulting or Advisory Role - Iovance Biotherapeutics
 
Alexander Go
No Relationships to Disclose
 
Vanessa Hsu
Consulting or Advisory Role - Immunocore
 
Abigail Fong
No Relationships to Disclose
 
Krupal Patel
No Relationships to Disclose
 
Hans Schoellhammer
No Relationships to Disclose
 
Laleh Melstrom
No Relationships to Disclose
 
Matthew Hedberg
No Relationships to Disclose
 
L. Elizabeth Budde
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb/Celgene; foresight; Kite/Gilead; nurix; Regeneron; Roche/Genentech
Research Funding - Amgen; AstraZeneca; Merck
Patents, Royalties, Other Intellectual Property - CCR4 CAR T cells for treatment of patients with CCR4 positive cancer.; CD33CAR for treatment of patients with CD33+ acute myeloid leukemia.
Travel, Accommodations, Expenses - AstraZeneca; Roche/Genentech
 
Stephen Forman
No Relationships to Disclose
 
Vijay Trisal
No Relationships to Disclose
 
Ravi Salgia
No Relationships to Disclose
 
Myo Htut
Consulting or Advisory Role - Iovance Biotherapeutics
 
Yan Xing
No Relationships to Disclose